Generics - Production, Generics

Filter

Current filters:

ProductionGenerics

Popular Filters

1 to 25 of 97 results

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

27-08-2014

Brazilian Minister of Health Arthur Chioro participated in the inauguration ceremony of NovaMed/EMS,…

BrazilEMS GroupFinancialGenericsNovaMedProduction

Generics production predicted to return to the USA due to quality concerns

Generics production predicted to return to the USA due to quality concerns

08-08-2014

Generics production represents a huge area of growth for the US market, which is partially driven by…

Business FinanceCPhI Pharma Insights USAGenericsProductionUSA

Indian generic drugmakers set to score from MPP deals on HIV drugs

Indian generic drugmakers set to score from MPP deals on HIV drugs

28-07-2014

Seven new sub-licensing agreements for the manufacture of generic HIV medicines and two new generation…

Anti-viralsGenericsIndiaLicensingPatentsProduction

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

Glenmark Pharma to set up new manufacturing facility in USA

Glenmark Pharma to set up new manufacturing facility in USA

17-07-2014

Indian drugmaker Glenmark Pharmaceuticals plans to set up a new manufacturing facility at Monroe Corporate…

GenericsGlenmark PharmaceuticalsProductionUSA

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Bahiafarma reopens manufacturing unit in Brazil to cut cost of drugs

Bahiafarma reopens manufacturing unit in Brazil to cut cost of drugs

09-07-2014

Brazil’s Bahia Foundation for Scientific Research and Technological Development, commonly known as…

Bahia Foundation for Scientific Research and Technological DevelopmentBrazilCabergolineCristaliaGenericsPharmaceuticalProduction

Hospira completes buy of Orchid's API production and R&D facility

Hospira completes buy of Orchid's API production and R&D facility

06-07-2014

US provider of injectable drugs and infusion technologies Hospira says it has completed the acquisition…

GenericsHospiraIndiaMergers & AcquisitionsOrchid Chemicals & PharmaceuticalsProduction

Esteve to launch new generic version of omeprazole

Esteve to launch new generic version of omeprazole

18-06-2014

Pensa Pharma, subsidiary of Spanish pharmaceutical company Grupo Esteve, has launched a new formulation…

Esteve GroupGastro-intestinalsGenericsOmeprazoleProductionSpain

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

05-06-2014

European regulatory authorities have finalized their assessment of reported non-compliance with Good…

EuropeGenericsIndiaProductionRanbaxy LaboratoriesRegulation

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

02-06-2014

USA-based Albany Molecular Research has signed a definitive agreement to acquire all of the outstanding…

Albany Molecular ResearchGenericsMergers & AcquisitionsOso BiopharmaceuticalsProduction

Russian PM visits country's first commercial manufacturing plant for MAb-based therapeutic proteins

20-05-2014

Russian Prime Minister Dmitri Medvedev on Monday visited the commercial manufacturing facility for monoclonal…

BiocadBiosimilarsGenericsOncologyProductionRussia

Novasep commissions 4 million-euro plant extension for commercial ADC payload manufacturing

15-05-2014

French ingredients company Novasep says that its 4 million-euro ($5.5 million) investment to expand its…

FranceGenericsNovasepOncologyProduction

Sun Pharma vows “appropriate action” as Ranbaxy merger halted

05-05-2014

In the wake of a suspension of its proposed $4 billion acquisition of domestic rival Ranbaxy Laboratories…

GenericsIndiaMergers & AcquisitionsProductionRanbaxy LaboratoriesSun Pharmaceutical IndustriesUSA

Indian govt plans to support a competitive pharma sector, especially for SMEs

Indian govt plans to support a competitive pharma sector, especially for SMEs

14-04-2014

In a bid to strengthen the existing infrastructure facilities and to enable the Indian pharmaceutical…

Asia-PacificGenericsIndiaMarkets & MarketingPoliticsProduction

Study produces map of pharma industry and API production in Brazil

Study produces map of pharma industry and API production in Brazil

28-03-2014

Brazil is failing to produce the number of active pharmaceutical ingredients in order to produce the…

BrazilGenericsMarkets & MarketingProductionSouth America

New HIV/AIDS drug will be offered through Brazil’s SUS

New HIV/AIDS drug will be offered through Brazil’s SUS

27-03-2014

A medicine that combines tenofovir (Gilead’s Viread) and lamivudine (GlaxoSmithKline’s Combivir)…

Anti-viralsBlanver FarmoquimicaBrazilGenericsLamivudineProductionSouth AmericaTenofovir Disoproxil Fumarate

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

Sun Pharma latest Indian generic drugmaker to fall foul of US FDA

14-03-2014

Even as India-based drug majors Ranbaxy and Wockhardt reel under the impact of US Food and Drug Administration…

Asia-PacificGenericsIndiaProductionRegulation

Ranbaxy temporarily suspends shipments from Toansa and Dewas plants

25-02-2014

Indian drugmaker Ranbaxy Laboratories has announced in a letter to the Stock Exchange that it has temporarily…

Asia-PacificDaiichi SankyoGenericsIndiaProductionRanbaxy Laboratories

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Another ban by US FDA on a Ranbaxy production facility

Another ban by US FDA on a Ranbaxy production facility

24-01-2014

As if the Indian drug major has not had enough negative news from the US regulator, the US Food and Drug…

Asia-PacificDaiichi SankyoGenericsIndiaNorth AmericaProductionRanbaxy LaboratoriesRegulationUSA

1 to 25 of 97 results

Back to top